← Evidence map

ArticleThoracic cancer2018

Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors.

Yali Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29575544